“Summary: Large-scale manufacture of treatment to cure Hepatitis C is feasible, with target prices of
US$100-250 per 12 week treatment course. These low prices could make widespread access to
HCV treatment in low and middle income countries a realistic goal.”
This study says “US$68-136 for sofosbuvir” per 12-week course. Compare to USD 84,000 in the US [ for this number, one reference among many here ].
Clin Infect Dis. (2014) doi: 10.1093/cid/ciu012
First published online: January 6, 2014